HomeDYN • NASDAQ
add
Dyne Therapeutics Inc
Previous close
$34.62
Day range
$33.69 - $34.92
Year range
$6.40 - $47.45
Market cap
3.40B USD
Avg Volume
1.68M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 71.96M | 7.83% |
Net income | -65.10M | -0.31% |
Net profit margin | — | — |
Earnings per share | -0.70 | 35.19% |
EBITDA | -71.56M | -7.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 778.84M | 274.92% |
Total assets | 825.88M | 228.49% |
Total liabilities | 50.69M | 13.80% |
Total equity | 775.19M | — |
Shares outstanding | 100.40M | — |
Price to book | 4.47 | — |
Return on assets | -26.69% | — |
Return on capital | -27.56% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -65.10M | -0.31% |
Cash from operations | -54.87M | 1.39% |
Cash from investing | 11.17M | -35.16% |
Cash from financing | 379.86M | 1,425.18% |
Net change in cash | 336.17M | 2,589.40% |
Free cash flow | -10.22M | 68.70% |
About
Founded
2017
Headquarters
Website
Employees
152
